Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Nutr ; 30(5): 578-84, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21474219

RESUMEN

BACKGROUND & AIMS: To assess the effect of an enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and anti-oxidants on the incidence of organ dysfunction and nosocomial infections in septic patients with acute lung injury or acute respiratory distress syndrome (ARDS) compared with a standard enteral diet. METHODS: This prospective, randomized, open-label study was performed in 11 Spanish intensive care units (ICU). Adult patients with sepsis and acute lung injury or ARDS were randomly allocated to receive either an EPA-GLA diet or a control diet. RESULTS: Of the 198 patients that were eligible, 160 were randomized and 132 were studied. Patient demographics, APACHE II and SOFA scores, and nutritional variables on admission were similar between the EPA-GLA diet and control diet groups. The EPA-GLA diet group showed a trend toward a decreased SOFA score, but it was not significant. No differences were observed in the PaO(2)/FiO(2) ratio or the days on mechanical ventilation between the groups. Incidence of infections was similar in the groups. The control group stayed longer in the ICU than the EPA-GLA diet group (16 vs. 18; p = 0.02). CONCLUSIONS: A diet enriched with EPA, GLA, and anti-oxidants does not improve gas exchange or decrease the incidence of novel organ failures in critically ill septic patients with acute lung injury or ARDS. Patients treated with the EPA-GLA diet stayed in the ICU for less time, but we did not find any differences in infectious complications.


Asunto(s)
Lesión Pulmonar Aguda/fisiopatología , Ácido Eicosapentaenoico/uso terapéutico , Nutrición Enteral , Insuficiencia Multiorgánica/prevención & control , Síndrome de Dificultad Respiratoria/fisiopatología , Sepsis/fisiopatología , Ácido gammalinolénico/uso terapéutico , Lesión Pulmonar Aguda/complicaciones , Lesión Pulmonar Aguda/terapia , Adulto , Anciano , Antioxidantes/uso terapéutico , Infección Hospitalaria/epidemiología , Infección Hospitalaria/prevención & control , Femenino , Alimentos Formulados/análisis , Humanos , Incidencia , Unidades de Cuidados Intensivos , Análisis de Intención de Tratar , Tiempo de Internación , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica/epidemiología , Insuficiencia Multiorgánica/etiología , Respiración Artificial , Síndrome de Dificultad Respiratoria/complicaciones , Síndrome de Dificultad Respiratoria/terapia , Sepsis/complicaciones , Sepsis/terapia , España/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA